Experimental treatment for Niemann-Pick disease type C1 appears safe, effective
NIH-led clinical trial suggests that drug slows progression of rare neurological disease.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Brain | Clinical Trials | National Institutes of Health (NIH) | Neurology | Niemann-Pick Disease